Correlation between serum lipoprotein associated phospholipase A2 level and renal damage in elders with type 2 diabetes mellitus

Correlation between serum lipoprotein associated phospholipase A2 level and renal damage in elders with type 2 diabetes mellitus

ObjectiveTo explore the correlation between serum lipoprotein associated phospholipase A2 （Lp-PLA2） and renal damage of diabetic kidney disease （DKD） in elders with type 2 diabetes mellitus （T2DM）.MethodsA total of 118 T2DM elders were recruited and divided into three groups according to urinary alb...

Full description

Saved in:

Bibliographic Details
Main Authors:	Xie Juan, Cheng Liang, Li Jing, Zhang Yi-yuan, Li Hai-lun
Format:	Article
Language:	zho
Published:	Editorial Department of Journal of Clinical Nephrology 2022-06-01
Series:	Linchuang shenzangbing zazhi
Subjects:	Elderly T2DM Diabetic kidney disease Lipoprotein associated phospholipase A2
Online Access:	http://www.lcszb.com/thesisDetails#10.3969/j.issn.1671-2390.2022.06.002
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Predictive value of serum lipoprotein-associated phospholipase A2 for coronary atherosclerotic heart disease in elderly patients with hypertension
by: Zhang Mimi, et al.
Published: (2025-03-01)

Effect of plasma lipoprotein-associated phospholipase A<sub>2</sub> levels on structure and function of heart in patients undergoing maintenance hemodialysis
by: WANG Yun-qian, et al.
Published: (2016-01-01)

Serum lipoprotein‐associated phospholipase A2 activity in Chinese patients with systemic lupus erythematosus
by: Jie Feng, et al.
Published: (2024-12-01)

Effects of combined therapy with atorvastatin and polyunsaturated omega-3 fatty acids on lipid profile, lipoprotein-associated phospholipase A2 and thromboxane
by: G. F. Piksina, et al.
Published: (2010-10-01)

Association of serum Metrnl levels and high-density lipoprotein cholesterol in patients with type 2 diabetes mellitus: a cross-sectional study
by: Chenxia Zhou, et al.
Published: (2024-10-01)

Correlationbetween the activity of lipoprotein-associated phospholipase A2 and blood lipid levels in hypertensive patients with different temperament and anxiety
by: G. A. Usenko, et al.
Published: (2014-12-01)

LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 IN CARDIOVASCULAR RISK STRATIFICATION AFTER CORONARY ANGIOPLASTY IN PATIENTS WITH TYPE 2 DIABETES: WHICH DECISION RULE THRESHOLD TO CHOOSE?
by: A. T. Teplyakov, et al.
Published: (2015-04-01)

Human phospholipases A2: a functional and evolutionary analysis
by: I. I. Turnaev, et al.
Published: (2023-01-01)

Value of M-type phospholipase A2 receptor in clinical diagnosis and treatment of membranous nephropathy:recent advances and current controversies
by: Wang Hui, et al.
Published: (2021-01-01)

The study of correlation between serum anti-phospholipase A2 receptor antibody and clinicopathology feature and the efficacy in patients with idiopathic membranous nephropathy
by: LI Wen-dong, et al.
Published: (2020-01-01)

Viperidae snake venom phospholipase A2 . Biochemical targets for the action of protein in the human blood circulatory system. Part 1 (review of literature)
by: L. V. Galebskaya, et al.
Published: (2022-05-01)

Viperidae snake venom phospholipase A2. Biochemical targets in the human blood circulatory system. Review. Part 2
by: L. V. Vasina, et al.
Published: (2024-04-01)

Serum phospholipase A2 and phosphoglycerate kinase 1 levels for prognostic assessment of endocrine therapy in elderly patients with prostate cancer
by: CAI Chunjie, ZHANG Jin
Published: (2025-02-01)

Development and Validation of a Nomogram-Based Risk Prediction Model for Diabetic Retinopathy in Elderly Adults with Type 2 Diabetes Mellitus
by: Chen M, et al.
Published: (2025-07-01)

The level and clinical significance of serum soluble M-type phospholipase A2 receptor in patients with primary membranous nephropathy
by: Zi-Han Wang, et al.
Published: (2025-12-01)

Predictive value of serum IgG/C3 levels for membranous nephropathy in diabetics with proteinuria and negative phospholipase A2 receptor antibody
by: Huan Wang, et al.
Published: (2024-12-01)

Contribution of individual phospholipase A2 enzymes to the cleavage of oxidized phospholipids in human blood plasma
by: Philipp Jokesch, et al.
Published: (2025-02-01)

Safety evaluation of the food enzyme phospholipase A2 from porcine pancreas
by: EFSA Panel on Food Contact Materials, Enzymes and Processing Aids (CEP), et al.
Published: (2023-04-01)

Nonlinear relationship between lumbar bone mineral density and high-density lipoprotein cholesterol in patients with type 2 diabetes
by: Yu-Hua He, et al.
Published: (2025-06-01)

Changes and significance of plasma Lp-PLA<sub>2</sub> levels in hemodialysis patients with autologous arteriovenous fistula
by: CHENG Yi, et al.
Published: (2020-01-01)

Overproduction and Characterization of Recombinant Soluble Trypanosoma brucei Phospholipase A2
by: Oluwafemi Abiodun Adepoju, et al.
Published: (2025-03-01)

Platelet-activating Factor–Acetyl Hydrolase is Associated with Dysregulated Expression of <i>Nrf2</i>-NQO1 Pathway in Metabolic Syndrome
by: Seema Garg, et al.
Published: (2025-05-01)

Clinical value of Lp-PLA2, LDL-C, HDL-C, hs-CRP, leukocyte, FPG and HbA1c in type 2 diabetes mellitus patients with acute ischemic stroke
by: Huimin Shen, et al.
Published: (2025-04-01)

The correlation between anti-phospholipase A2 receptor antibodies and hypercoagulability in patients with idiopathic membranous nephropathy
by: Yunyun Liu, et al.
Published: (2024-12-01)

Estimation of Serum Osteocalcin Levels in Osteoporotic Postmenopausal Iraqi Women with Type 2 Diabetes Mellitus
by: Baghdad Science Journal
Published: (2014-12-01)

A Lipidomic Approach to Studying the Downregulation of Free Fatty Acids by Cytosolic Phospholipase A<sub>2</sub> Inhibitors
by: Asimina Bourboula, et al.
Published: (2025-04-01)

Inhibiting the Interaction Between Phospholipase A2 and Phospholipid Serine as a Potential Therapeutic Method for Pneumonia
by: Jianyu Wang, et al.
Published: (2025-07-01)

Inhibition of a Myotoxic Phospholipase A2 isolated from Crotalus durissus cumanensis by Pentacyclic Triterpenes
by: Laura Cardona-Alzate, et al.
Published: (2025-03-01)

Fibrinogen-albumin ratio predicts treatment response in phospholipase A2 receptor-associated membranous nephropathy with nephrotic syndrome
by: Suyan Duan, et al.
Published: (2024-12-01)

Metformin Increases Serum Isthmin-1 Levels and Lowers Low-Density Lipoprotein: Potential Implications for Lipid Metabolism in T2DM
by: Merve Yilmaz Bozoglan, et al.
Published: (2025-03-01)

Phase 1b/2a Study Assessing the Safety and Efficacy of Felzartamab in Anti-Phospholipase A2 Receptor Autoantibody–Positive Primary Membranous Nephropathy
by: Brad H. Rovin, et al.
Published: (2024-09-01)

Proteomics Analysis of the Regulatory Mechanism of the Calcium-Independent Phospholipase A2 Activity of Peroxiredoxin 6 on Beef Tenderization
by: LIU Jitong, WANG Xinyi, ZHANG Yimin, ZHU Lixian, LIANG Rongrong, MAO Yanwei
Published: (2025-06-01)

Decoding the role of serum cholinesterase among type 2 diabetes mellitus patients at RIMS, Ranchi – A hospital-based study
by: Avijit Saha, et al.
Published: (2025-02-01)

The Role of Paternal History of Type 2 Diabetes Mellitus on Prediabetes Status among The Offspring of Type 2 Diabetes Mellitus Patients
by: Maulidia Ekaputri, et al.
Published: (2019-12-01)

Study of the cytotoxic effect of secretory phospholipase A<sub>2</sub> of <i>Vipera nikolskii</i> venom on the model of HeLа and ECV340 cell lines
by: M. A. Solovyeva, et al.
Published: (2024-12-01)

Expression and significance of phospholipase A2 receptor and thrombospondin type-1 domain 7A in idiopathic membranous nephropathy
by: LI Fei, et al.
Published: (2019-01-01)

GLP-1 and SGLT2 Therapies in Type 2 Diabetes Mellitus. Cutting-Edge Approaches to Advancing Diabetes Care
by: Agnieszka Parfianowicz, et al.
Published: (2025-02-01)

An Experimental Model of Acute Pulmonary Damage Induced by the Phospholipase A<sub>2</sub>-Rich Venom of the Snake <i>Pseudechis papuanus</i>
by: Daniela Solano, et al.
Published: (2025-06-01)

Association Between Serum Folic Acid Levels and Type 2 Diabetes Mellitus in Overweight or Obese Patients: A Retrospective Study
by: Dai Y, et al.
Published: (2025-07-01)

Impact of Metformin Therapy on Vitamin B12 Levels in Patients With Type 2 Diabetes Mellitus
by: Sahar H. Mahmoud, et al.
Published: (2025-05-01)